8 mechanisms, 2 products, 1 protocol
The BPC protocol is based on a simple pharmacokinetic observation: no single product can simultaneously address all factors behind weight gain and cellulite. LIPOSLIM™ acts on 8 systemic mechanisms — satiety, blood sugar regulation, thermogenesis, lipolysis, lipogenesis inhibition, microbiome balance, water drainage, optimised absorption — while LYMPHEA™ concentrates its action locally on topical lipolysis, lymphatic drainage, and skin restructuring. Together, they form the most comprehensive double lever available in the nutri-cosmetic space.
The 3 EFSA claims: what they actually guarantee
An EFSA claim is not a marketing argument: it is a scientific decision made after examination of all available clinical studies by an independent expert committee. LIPOSLIM™ cumulates three validated claims: glucomannan for "contributing to weight loss in the context of an energy-restricted diet" (ID 854), chromium for "maintenance of normal blood glucose levels" (ID 777) and "contribution to normal macronutrient metabolism" (ID 776). No French DTC competitor presents this level of regulatory validation on a single product.
Day 0, Day 15, Day 30: the transformation milestones
Day 0: Begin the protocol with reference measurements and photos. Day 3–5: First satiety effect from glucomannan (natural reduction of mid-morning cravings). Day 7–10: Lightness in the legs with LYMPHEA™ (escin action on venous return). Day 14–18: Onset of visible thermogenic effects (slight post-morning warmth from Grains of Paradise). Day 25–30: Measurable results in waist circumference and visible improvement in skin texture. The recommended duration for a complete effect on connective septa fibrosis is 56 days.